Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
April 24, 2015

Recent Stories of Interest

From Drug Benefit News - Nearly a year after the last of the valid patents on Teva Pharmaceutical Industries Ltd.’s multiple sclerosis drug Copaxone (glatiramer acetate) expired, the FDA on April 16 cleared Sandoz Inc. and Momenta Pharmaceuticals, Inc. to market Glatopa, the first substitutable generic version of the daily injectable therapy. While entry of the generic has the potential to significantly lower costs in the multiple sclerosis category, there are several uncertainties that may impede successful penetration of the market, say industry insiders. Read more

After mulling a proposed rule on generic drug labeling for the last… Read more

In a move that surprised many industry analysts, UnitedHealth Group on March… Read more

Although the Alzheimer’s disease drug pipeline has been plagued by failures and… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

April 21, 2015
Compounded Drugs Drove Employee Costs in 2014

Compounded medicine once again drove workers' compensation drug costs in 2014, says new Express Scripts report.

April 16, 2015
FDA Approves First Generic Copaxone for MS

The FDA approved Sandoz’s Glatopa, the first generic version of Teva’s multiple sclerosis treatment Copaxone (glatiramer acetate) in a 20 mg/ml once-daily injection

April 15, 2015
HHS Will Investigate Generic Drug Inflation

The Office of the Inspector General plans to investigate recent price increases for generic drugs paid through Medicaid.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?